An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Etravirine (ETR) in Combination With Other Antiretrovirals (ARVs) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects.
Phase of Trial: Phase IV
Latest Information Update: 06 Mar 2017
At a glance
- Drugs Etravirine (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Adverse reactions
- Acronyms VIOLIN
- Sponsors Janssen R&D Ireland
- 10 Jun 2017 Biomarkers information updated
- 18 Apr 2013 Planned end date changed from 1 Dec 2013 to 1 Sep 2015 as reported by ClinicalTrials.gov.
- 10 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.